PROGRAM BRIEF: PSI/MYANMAR. Improving Malaria Case Management in the Private Sector: Artemisinin Monotherapy Replacement (AMTR) Project. psi.
|
|
- Asher Ward
- 5 years ago
- Views:
Transcription
1 PROGRAM BRIEF: PSI/MYANMAR Improving Malaria Case Management in the Private Sector: Artemisinin Monotherapy Replacement (AMTR) Project psi.org
2 1 Artemisinin Monotherapy Replacement Project AMTR PROJECT available in 70% of private sector outlets. In 2012, oral artemisinin monotherapy was Continued use of oral artemisinin-based monotherapy (AMT) is widely considered to be one of the main contributing factors to the development and spread of resistance to artemisinin and its derivatives. In 2012, alarmingly high rates of oral AMT availability and use were detected in the private sector where the majority of people seek care across Myanmar. In response to this situation, the international Non-Profit Organization (NGO) of Population Services International (PSI) implemented the Artemisinin Monotherapy Replacement Malaria (AMTR) project. The projects aims to rapidly displace oral AMT with subsidized, quality assured Artemisinin-based Combination Therapy (ACT) in the private sector. This quality assured ACT is distributed through AA Pharmacy and Polygold key suppliers in the country who previously distributed most of the oral AMT found in Eastern Myanmar. Distribution of oral AMT was replaced with the sale of quality assured ACT branded as SupaArte. An additional brand, Artel Plus, was introduced in 2013 to facilitate market competition. Both SupaArte and Artel Plus are branded with a quality seal. Complementing the private sector distribution of subsidized ACT are a variety of demand creation activities targeting antimalarial providers and patients. Underserved outlets (pharmacies, general retailers and itinerant drug vendors) are also targeted by product promoters in project intervention areas. These types of outlets are referred to as priority outlets. Private facilities and community health workers ( non-priority outlets) who have access to the public sector or other INGO/NGO did not receive this product promoter outreach intervention. To monitor the project, a census of all private sector outlets was completed, and yearly outlet surveys have been conducted in both intervention (where product promoters operate) and comparison areas. These surveys screened the availability, market share and price of antimalarials. What types of outlets have antimalarials? In 2012, one in five priority outlets stocked an antimalarial medicine. In 2015, less than one in ten priority outlets stocked an antimalarial medicine, reflecting a gradual decline in availability over the years among these outlet types. This overall decrease is an expected response to the falling number of malaria cases in the country. How available is oral artemisinin monotherapy? In 2012, oral AMT was available in 70 percent of priority outlets. By 2015, only one in three outlets was found to stock this medicine in the intervention area. However, a 15 percent increase in availability of oral AMT was observed between 2014 and 2015 in the intervention area. Oral AMT availability was higher in the comparison area than the intervention area with one in three outlets stocking this class of medicine in What brands of oral artemisinin monotherapy are being sold and for what price? Most of the packages found in Eastern Myanmar in 2015 were Artesunate manufactured by Mediplantex in Vietnam. Providers recalled that customers typically ask for these medicines by name and rather than selling a full course, will provide a patient with two or three tablets for around 500 Myanmar kyat. Most of the oral AMT in stock at the time of the survey was not expired. How available is quality assured ACT?
3 Artemisinin Monotherapy Replacement Project Priority outlets: pharmacies, general retailers and itinerant drug vendors are targeted by product promoters in the AMTR Project s intervention area. Availability of Oral Artemisinin Monotherapy among Priority Outlets in the Intervention Area ( ) 100% Availability of oral artemisinin monotherapy decreases over time among priority outlets in the intervention area. Slight increases are observed between 2014 and % 50% 50% 30% 10%
4 3 Artemisinin Monotherapy Replacement Project Antimalarial market share among priority outlet types in intervention and comparison areas ( ) Quality-assured ACT market share increases over time among priority outlets in the intervention area from < 5% in 2012 to over 50% in Increases in quality assured ACT are found between 2012 & 2015 among priority outlets in the intervention area. In 2015, 62% of priotiy outlets stock a quality assured ACT. 4% % % % 2015 In 2012 availability of any quality assured ACT was less than 10 percent among priority outlets in both the comparison and intervention area. By 2015, quality assured ACT was available in 60 percent of priority outlets in the intervention area. Though increases were also found among outlets in the comparison area, availability only increased to 20 percent in Is the quality assured ACT affordable? The recommended retail selling price of the branded ACT is 500 Myanmar Kyat. In 2015, 90% of the priority outlets that stock the medicine reportedly sell the ACT for this price. share in PSI is conducting further study to better understand what may account for this suprising increase. To what extent are rapid diagnostic tests available? Availability of malaria rapid diagnostic tests (RDTs) among antimalarial-stocking outlets has increased slightly over time in the intervention area, but still remains low among priority outlets in Market Share Market share of quality assured ACT has increased from 2012 to The majority of quality assured ACT packages sold in 2015 were those with the quality seal. Since 2013, the market share of quality assured ACT has consistently been higher in the intervention area than the comparison area. Oral AMT stubbornly remains in the market. Slight increases of oral AMT were observed between 2014 and 2015 in the intervention area, with oral AMT comprising 25 percent of the market
5 Artemisinin Monotherapy Replacement Project % Availability of RDT among priority outlets in 2015 Conclusion Considerable progress has been made to increase access to high quality, affordable ACT in Eastern Myanmar. Supportive interventions have been effective in helping to maximize the benefit of subsidized quality assured ACT distribution. Availability and sale of oral AMT persists and appears to have increased over the last two years. This points to the need to enforce the current policy banning the importation of non-licensed oral AMT products and prohibiting any new licenses as a means of creating a supportive environment for on-going interventions in Eastern Myanmar and throughout the country. Malaria elimination strategies must ensure improved case management in the private sector, where most febrile patients seek treatment. This can be done through improved availability of both ACT and RDT. Future strategies will therefore learn from the ACT experience to increase the availability of RDTs in the private sector, and expand all project activities into Western Myanmar. For further information contact: Dr Hnin Su Su Khin, PSI/Myanmar Malaria Director hsskhin@psimyanmar.org
6
Using supply side evidence to inform oral artemisinin monotherapy replacement in Myanmar: a case study
Malaria Journal Using supply side evidence to inform oral artemisinin monotherapy replacement in Myanmar: a case study Khin et al. Khin et al. Malar J (2016) 15:418 DOI 10.1186/s12936-016-1385-4 DOI 10.1186/s12936-016-1385-4
More informationARTEMISININ RESISTANCE IN THE GREATER MEKONG SUBREGION
1 ARTEMISININ RESISTANCE IN THE GREATER MEKONG SUBREGION Key messages The situation in the Greater Mekong Subregion is critical. We are at a tipping point. If resistance to artemisinin emerges elsewhere,
More informationThe global challenge of antimalarial drug resistance
The global challenge of antimalarial drug resistance MMV Stakeholders Meeting New Delhi, India 8 November 2012 Robert D. Newman, MD, MPH Director, Global Malaria Programme newmanr@who.int AR Situation
More informationin the Greater Mekong Sub-region
in the Greater Mekong Sub-region 05 07 August 2013 Towards Multi-sectoral Actions to Combat Malaria Drug Resistance in the Greater Mekong Sub-region Dr. Leonard Ortega Regional Adviser, Malaria WHO South
More informationAffordable Medicines Facility-malaria (AMFm): Innovative Financing for Better Access
Affordable Medicines Facility-malaria (AMFm): Innovative Financing for Better Access Medicines For Malaria Venture Stakeholders Meeting, Dar-es-Salaam, 3 June 2011 Olusoji Adeyi, MD, DrPH, MBA Director
More informationStatus report on artemisinin resistance
Status report on artemisinin resistance Key messages 1. artemisinin resistance and delayed parasite clearance The term artemisinin resistance 1 is used to describe delayed parasite clearance observed after
More informationREGIONAL ARTEMISININ MALARIA INITIATIVE (RAI)
REGIONAL ARTEMISININ MALARIA INITIATIVE (RAI) IMPLEMENTATION, ACHIEVEMENT AND LESSONS LEARNT REGIONAL TRAINING WORKSHOP ON ANTIMICROBIAL RESISTANCE (AMR) 15-18 NOVEMBER 2016 BANGKOK, THAILAND Background
More informationGLOBAL MALARIA DIAGNOSTIC AND ARTEMISININ TREATMENT COMMODITIES DEMAND FORECAST
FORECAST REPORT GLOBAL MALARIA DIAGNOSTIC AND ARTEMISININ TREATMENT COMMODITIES DEMAND FORECAST 2015 2018 April 25, 2016 2016 World Health Organization (Acting as the host organization for the Secretariat
More informationDELAYING ARTEMISININ RESISTANCE: FRAMING POLICY RESPONSE FOR AN EMERGING PUBLIC HEALTH CONCERN
DELAYING ARTEMISININ RESISTANCE: FRAMING POLICY RESPONSE FOR AN EMERGING PUBLIC HEALTH CONCERN Introduction Every year more than 200 million cases of Malaria occur and nearly 600,000 deaths are estimated
More informationCambodia: From Control to Elimination
Cambodia: From Control to Elimination Ministry of Health National Centre for Parasitology, Entomology and Malaria Control (CNM) Dr. Kheng Sim Presentation at APMEN Meeting, 8 May 212 History of Malaria
More informationMalaria Journal. Open Access RESEARCH. ACTwatch Group 1*, Paul N. Newton 2,3, Kara Hanson 3 and Catherine Goodman 3
Malaria Journal Do anti malarials in Africa meet quality standards? The market penetration of non quality assured artemisinin combination therapy in eight African countries ACTwatch Group et al. ACTwatch
More informationTowards malaria elimination: ADB-supported work at Myanmar FDA
Towards malaria elimination: ADB-supported work at Myanmar FDA Valerio Reggi 25 January 2018 Disclaimer: The views expressed in this paper/presentation are the views of the author and do not necessarily
More informationArtemisinin resistance: global situation, update and next steps. WHO Webinar
Artemisinin resistance: global situation, update and next steps WHO Webinar Definitions Terminology: multidrug-resistant, extensively drug-resistant and pandrug-resistance (Magiorakos et al., 2011); Antimalarial
More informationGuyana Shield Meeting on the Implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America
Guyana Shield Meeting on the Implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America Paramaribo, Suriname 12-14 July 2016 Background Artemisinin-based
More informationASEAN Regulatory Harmonisation and Approval Process
ASEAN Regulatory Harmonisation and Approval Process Selvaraja Seerangam National Pharmaceutical Control Bureau Ministry of Health Malaysia Open Forum on Key Issues on TB Drug Development- 18-19 August
More informationColombia on the Frontier of Biomedicine. Zagaya
Colombia on the Frontier of Biomedicine An Intersectorial Meeting for Research, Innovation and Health February 27 & 28, 2012 Hotel Intercontinental, Cali, Colombia Kay Monroe, Executive Director Zagaya
More informationStatus report on artemisinin resistance
Status report on artemisinin resistance Key messages 1. artemisinin resistance and delayed parasite clearance The term partial artemisinin resistance 1 is used to describe delayed parasite clearance observed
More informationKEY FINDINGS. Antony Ellman. Malcolm Cutler. FSC Development Services. Natural Resources Institute
ARTEMISININ CONFERENCE, MADAGASCAR KEY FINDINGS OF THE CONFERENCE Antony Ellman Natural Resources Institute Malcolm Cutler FSC Development Services Artemisinin Conference, Madagascar, 12 14 October 2010
More informationARTEMISININ RESISTANCE
EMERGENCY RESPONSE TO ARTEMISININ RESISTANCE IN THE GREATER MEKONG SUBREGION REGIONAL Framework for action 2013-2015 ISBN 978 92 4 150532 1 REGIONAL framework for action 2013-2015 Emergency response to
More informationMalaria Consortium Myanmar
Malaria Consortium Myanmar Malaria Consortium has become one of the world s leading specialist non-profit organisations dedicated to improving the lives of the poor and marginalised in Asia and Africa.
More informationUNITAID s approach to funding innovations in TB diagnosis and treatment Robert Matiru & Janet Ginnard, UNITAID Geneva, 29 April 2015
UNITAID UNITAID s approach to funding innovations in TB diagnosis and treatment Robert Matiru & Janet Ginnard, UNITAID Geneva, 29 April 2015 Page 2 UNITAID's role in the global response By connecting the
More informationalaria2012 Malaria in the Asia-Pacific: Challenges and opportunities for access to quality malaria medicines and other technologies Paper 3
alaria2012 Saving Lives in the Asia-Pacific Malaria in the Asia-Pacific: Challenges and opportunities for access to quality malaria medicines and other technologies Paper 3 Malaria in the Asia-Pacific:
More informationMalaria Consortium Asia provides technical assistance to countries in developing winning proposals for resource mobilisation in the GMS,
Asia Who We Are The principal aim of Malaria Consortium is the prevention and treatment of disease, particularly but not exclusively malaria, among the poorest and most at risk. Malaria Consortium staff
More informationReport. Whitefield Place, Fax: + 229
Evidence for Malaria Medicines Policy Outlet Survey Republic of Beninn 2011 Survey Report Country Program Coordinator Cyprien Zinsou Association Béninoise pour le Marketing Social Lot 919 Immeuble Montcho
More informationAnalysis of the Regulatory Capacity to Assure the Quality of Antimalarial Medicines in Selected Countries of the Greater Mekong Subregion of Asia
Analysis of the Regulatory Capacity to Assure the Quality of Antimalarial Medicines in Selected Countries of the Greater Mekong Subregion of Asia March 2015 Analysis of the Regulatory Capacity to Assure
More informationCCM-Thailand Round 9 malaria proposal to the GFATM. Snapshot information to interested partners
ANNEX 3 CCM-Thailand Round 9 malaria proposal to the GFATM Snapshot information to interested partners Draft October 1 st, 2008 I. Context Huge strides have been made in the last 10 years to reduce the
More informationOutlet Survey Kingdom of Cambodia 2011 Survey Report
Evidence for Malaria Medicines Policy Outlet Survey Kingdom of Cambodia 2011 Survey Report Country Program Coordinator Mr.Phok Sochea Research Manager Population Services International/Cambodia No. 29,
More informationReport of the informal consultation on. Myanmar Artemisinin Resistance Containment (MARC)
Report of the informal consultation on Myanmar Artemisinin Resistance Containment (MARC) Nay Pyi Taw, 4 5 April, 2011 1 Contents Executive Summary... 3 Acronyms... 6 1. Introduction... 7 2. Opening session...
More informationArtemisinin Scenario Analysis Summary of findings. October, 2009
Artemisinin Scenario Analysis Summary of findings October, 2009 Acknowledgements We would like to thank the following individuals who provided their input to this analysis: CHAI Justin Cohen, Sanjay Patel
More informationUNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview
UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview December 2009 UNITAID Mission UNITAID's Mission Scale up access to treatment for HIV/AIDS, malaria and TB Leverage price reductions of quality
More informationalaria2012 Malaria in the Asia-Pacific: The role of the private sector in ensuring equity and access to services Paper 5
alaria2012 Saving Lives in the Asia-Pacific Malaria in the Asia-Pacific: The role of the private sector in ensuring equity and access to services Paper 5 Malaria in the Asia-Pacific: The role of the private
More informationIntellectual Property Policy. DNDi POLICIES
Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments
More informationObjective 3.1: Provide or stimulate provision by the private sector of affordable housing units.
3. HOUSING ELEMENT The purpose of this element is to provide plans and policies that will assist the City in meeting identified or projected deficits in the supply of housing, correcting substandard or
More informationWIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants
WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants Topic 12 Managing IP in Public-Private Partnerships, Strategic Alliances,
More informationRecent Trend of Generic Medicines Market In Japan
Recent Trend of Generic Medicines Market In Japan Joint 22 nd EGA and 19 th IGBA Annual Conference Dubrovnik, Croatia 9 June, 2016 Itsuro Yoshida President of Japan Generic Medicines Association Copyright
More informationOverview on Medicines Regulation: regulatory cooperation and harmonization in focus
Overview on Medicines Regulation: regulatory cooperation and harmonization in focus Dr Samvel Azatyan Manager, Medicines Regulatory Support Programme Quality Assurance and Safety: Medicines Essential Medicines
More informationContents. Definition of Integrated Innovation. Questions to consider when applying Integrated Innovation to your proposed solution
Integrated Contents Definition of Integrated Examples of Integrated Questions to consider when applying Integrated to your proposed solution 1 What is Integrated? is the development and application of
More informationThe case for quality
The case for quality Around the world, up to two billion people lack access to quality essential medicines. Poor-quality medicines undermine the treatment of some of the world s most pressing diseases,
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationChapter 1 Introduction and Concepts
Chapter 1 Introduction and Concepts Chapter 1 Introduction and Concepts OVERVIEW Programmable automation technologies are attracting attention as outgrowths of the evolution of computer and communications
More informationSectoral Patterns of Technical Change
Sectoral Patterns of Technical Change Chapter 7, Miozzo, M. & Walsh, V., International Competitiveness and Technological Change, Oxford University Press. Overview Introduction Why should we classify sectoral
More informationA Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei
A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical
More informationCounterfeit medical products
SIXTY-FIRST WORLD HEALTH ASSEMBLY A61/16 Provisional agenda item 11.13 7 April 2008 Counterfeit medical products Report by the Secretariat 1. Counterfeiting medical products, from their manufacture to
More informationTwenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years
Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints
More informationIntellectual Property Management Medicines for Malaria Venture. Life Sciences Symposium WIPO 15 December 2008
Intellectual Property Management Medicines for Malaria Venture Life Sciences Symposium WIPO 15 December 2008 1 Structure of the presentation 1. MMV at a glance - PPP model 2. MMV and Intellectual Property
More informationFRAMEWORK FOR ARTEMISININ RESISTANCE PREVENTION, CONTAINMENT, AND ELIMINATION IN SOUTH AMERICA
FRAMEWORK FOR ARTEMISININ RESISTANCE PREVENTION, CONTAINMENT, AND ELIMINATION IN SOUTH AMERICA FRAMEWORK FOR ARTEMISININ RESISTANCE PREVENTION, CONTAINMENT, AND ELIMINATION IN SOUTH AMERICA Washington,
More informationJOB DESCRIPTION. Department: Technical Length of contract: 3 years renewable. Reporting to: Chief of Party Direct reports: Numbers to be confirmed
JOB DESCRIPTION Job title: Technical Director and Malaria Specialist Location: Luanda Angola Department: Technical Length of contract: 3 years renewable Role type: Global Grade: 10 Travel involved: Frequent
More informationObjectives ECONOMIC GROWTH CHAPTER
9 ECONOMIC GROWTH CHAPTER Objectives After studying this chapter, you will able to Describe the long-term growth trends in the United States and other countries and regions Identify the main sources of
More informationWRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010
WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010 Prepared & Presented by: Gwen Connon, Contract Specialist, WRHA Contracting Services Sarah Kelso, Manager, Clinical Engineering,
More informationWhat We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012
What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report: The Case for Change 1 Report of What We Heard: The Case for Change Consultation
More informationEXECUTIVE SUMMARY. Robot sales to the fabricated metal products industry, the chemical industry and the food industry increased substantially.
2006 World Robot Market EXECUTIVE SUMMARY Total world-wide sales: 112,200 units, down 11% on 2005 World total stock of operational industrial robots: 951,000 units,3% greater than 2005 The world market
More informationLEAD IN SOLVENT-BASED PAINTS FOR HOME USE IN TAJIKISTAN
LEAD IN SOLVENT-BASED PAINTS FOR HOME USE IN TAJIKISTAN English Summary October 2016 IPEN is a leading global network of non-governmental organizations (NGOs) working in more than 100 developing countries
More informationStanding Committee on the Law of Patents
E SCP/24/4 ORIGINAL: ENGLISH DATE: JUNE 29, 2016 Standing Committee on the Law of Patents Twenty-Fourth Session Geneva, June 27 to 30, 2016 PROPOSAL BY THE AFRICAN GROUP FOR A WIPO WORK PROGRAM ON PATENTS
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationGlobal citizenship at HP. Corporate accountability and governance. Overarching message
Global citizenship at HP Overarching message With HP s global reach comes global responsibility. We take our role seriously by being an economic, intellectual and social asset to the communities in which
More informationFebruary 25, 2011 Government of Alberta Rural Broadband Response to
February 25, 2011 Government of Alberta Rural Broadband Response to Canada Gazette Notice SMSE-018-10 Consultation on a Policy and Technical Framework for the 700 MHz Band and Aspects Related to Commercial
More informationVirtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12: 834-838. Health law Intellectual property and access to medicine for the poor by Tara Leevy, LLB, LLM India
More informationQuality assurance in the supply chain for pharmaceuticals from the WHO perspective
1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation
More informationINTEGRATING INNOVATION AND CREATIVITY INTO NATIONAL POLICIES AND STRATEGIES OGADA T.
INTEGRATING INNOVATION AND CREATIVITY INTO NATIONAL POLICIES AND STRATEGIES OGADA T. High-Level Meeting for Members of Parliament of ARIPO Member States : Strategic Use of IP System for Economic, Cultural
More informationIpca Laboratories Limited
WHO / MMV Conference 2010 Laboratories Limited Partnering Healthcare Globally 12-14 th October 2010 Murali Sarma Vice - President & Head Mission Malaria 02/11/10 2 Overview Present Management since 1975
More informationTechnology and Competitiveness in Vietnam
Technology and Competitiveness in Vietnam General Statistics Office, Hanoi, Vietnam July 3 rd, 2014 Prof. Carol Newman, Trinity College Dublin Prof. Finn Tarp, University of Copenhagen and UNU-WIDER 1
More informationINTRODUCTION. The 2015 Brookings Blum Roundtable was convened to explore how digital technologies might disrupt global development.
INTRODUCTION The 2015 Brookings Blum Roundtable was convened to explore how digital technologies might disrupt global development. Our intention was to imagine a world 10 years from now where digital technologies
More informationIntellectual property governance and strategic value creation:
Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita
More informationDHA piperaquine as an eradication tool in Myanmar
DHA piperaquine as an eradication tool in Myanmar Myaing Myaing Nyunt MD PhD Celebrating 15 years of MMV Siam Reap, Cambodia 25 February 2015 Evidence and action for malaria elimination in Myanmar Evidence:
More informationITU/ITSO Workshop on Satellite Communications, AFRALTI, Nairobi Kenya, 17-21, July, Policy and Regulatory Guidelines for Satellite Services
ITU/ITSO Workshop on Satellite Communications, AFRALTI, Nairobi Kenya, 17-21, July, 2017 Policy and Regulatory Guidelines for Satellite Services Presenter: E. Kasule Musisi ITSO Consultant Email: kasule@datafundi.com
More informationGlobal Artemisinin Manufacturers Consultation
Global Artemisinin Manufacturers Consultation Chengdu Meeting September 5-7, 2016, Chengdu, China The Global Fund Procurement Strategy on the Artemisinin market is currently under development and may be
More informationMAXIMIZING THE HEALTH IMPACT OF DIAGNOSTIC SOLUTIONS ACCESS STRATEGY 2018
MAXIMIZING THE HEALTH IMPACT OF DIAGNOSTIC SOLUTIONS ACCESS STRATEGY 2018 ABOUT FIND FIND was founded in 2003 to bridge existing development gaps for essential diagnostics by initiating and coordinating
More informationExecutive Summary World Robotics 2018 Industrial Robots
Executive Summary World Robotics 2018 Industrial Robots 13 Executive Summary World Robotics 2018 Industrial Robots Robot Sales 2017: Impressive growth In 2017, robot sales increased by 30% to 381,335 units,
More informationSupporting Innovation through Regulation and Science
Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers
More informationTrends, challenges and opportunities for CPs
Trends, challenges and opportunities for CPs Andrea Manfrin Clinical Lecturer in Pharmacy Practice a.manfrin@kent.ac.uk Outlines Trends Challenges Opportunities Managing ADRs Management style Managing
More information16502/14 GT/nj 1 DG G 3 C
Council of the European Union Brussels, 8 December 2014 (OR. en) 16502/14 OUTCOME OF PROCEEDINGS From: To: Council Delegations ESPACE 92 COMPET 661 RECH 470 IND 372 TRANS 576 CSDP/PSDC 714 PESC 1279 EMPL
More informationLecture 22 ROLE OF CONSULTANCY ORGANISATIONS
Lecture 22 ROLE OF CONSULTANCY ORGANISATIONS Learning Objectives Consulting Model Consulting Matrix Introduction In competitive and constantly changing marketing conditions, the production of quality goods
More informationBuilding Foundations for Robust Quality Assurance Systems in Myanmar. Technical Brief September President s Malaria Initiative
Building Foundations for Robust Quality Assurance Systems in Myanmar Technical Brief September 2018 President s Malaria Initiative Background In recent years, Myanmar has made dramatic progress in combatting
More informationHow New Jersey's Economy Benefits from International Trade & Investment
How New Jersey's Economy Benefits from International Trade & Investment With more than 95 percent of the world s population and 80 percent of the world s purchasing power outside the United States, future
More information1. If an individual knows a field too well, it can stifle his ability to come up with solutions that require an alternative perspective.
Chapter 02 Sources of Innovation / Questions 1. If an individual knows a field too well, it can stifle his ability to come up with solutions that require an alternative perspective. 2. An organization's
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More informationGrowing and promoting Handmade [Cape]
Growing and promoting Handmade [Cape] IN THIS PRESENTATION WE WILL LOOK AT:- What is Craft? Craft as an Economic Activity HOW THE CCDI OPERATES Databases @ CCDI Creativity, Design & Innovation Centre PLUS
More informationNEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
More informationImproving Pharmaceutical Sector Transparency and Accountability. Medicines Transparency Alliance- Ghana. Phase 2. Workplan
Improving Pharmaceutical Sector Transparency and Accountability Medicines Transparency Alliance- Ghana Phase 2 Workplan 2012-2015 Proposal Submitted To International Meta Secretariat December 2012 1 ABBREVIATIONS...3
More informationTapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, LONAVALA
COMBATING COUNTERFEIT DRUGS WITH PACKAGING TECHNOLOGY Tapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, 2009 -LONAVALA Content Counterfeit Medicines:
More informationMalaria treatment policy change in Uganda: what role did evidence play?
Nabyonga-Orem et al. Malaria Journal 2014, 13:345 RESEARCH Open Access Malaria treatment policy change in Uganda: what role did evidence play? Juliet Nabyonga-Orem 1*, Freddie Ssengooba 2, Jean Macq 3
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationQuality of Artemisinin-Containing Antimalarials in Tanzania s Private Sector Results from a Nationally Representative Outlet Survey
Am. J. Trop. Med. Hyg., 92(Suppl 6), 2015, pp. 75 86 doi:10.4269/ajtmh.14-0544 Copyright 2015 by The American Society of Tropical Medicine and Hygiene Quality of Artemisinin-Containing Antimalarials in
More informationAll WiFi Projects are Not the Same: a comparison of major community wireless plans
All WiFi Projects are Not the Same: a comparison of major community wireless plans By Tom Asp, Principal Engineer and Business Analyst, Columbia Telecommunications Corporation We are witness to the birth
More informationSpeed Innovation Happiness. Corporate Overview
Corporate Overview Contents Bilcare Overview Businesses Business Strategy Financial Overview 2 Bilcare Overview 3 Bilcare Overview Our Objective Vision Delivering Innovation Transforming Lives Values Speed
More informationContaining artemisinin resistance of Plasmodium falciparum in Myanmar: achievements, challenges and the way forward
Policy and practice Containing artemisinin resistance of Plasmodium falciparum in Myanmar: achievements, challenges and the way forward Access this article online Website: www.searo.who.int/ publications/journals/seajph
More informationKaren Mossberger, Caroline Tolbert and Christopher Anderson October 27, :30am
1 of 5 3/6/2015 6:48 AM «Previous Next» Karen Mossberger, Caroline Tolbert and Christopher Anderson October 27, 2014 7:30am The Internet has generated huge economic gains for people all over the world.
More informationRADIOLOGY August 2017
USA EUROPE CHINA BRAZIL The current challenges faced by a Radiologist Too many patients 38% 45% 47% 53% Long working hours 36% 40% 50% 52% Troubleshooting IT and technical issues 14% 23% 28% 33% Limitations
More informationBoundaryless Hospital - Rethink and Redefine Health Care Management. New Chains of Value Creation
Boundaryless Hospital - Rethink and Redefine Health Care Management New Chains of Value Creation Sören T. Eichhorst, MD PhD Partner and Head of McKinsey Hospital Institute Cologne, Germany PROPRIETARY
More informationOffice of Small and Medium Enterprises (OSME) Bureau des petites et moyennes entreprises (BPME)
Build in Canada Innovation Program To Kickstart Innovation Programme d innovation Construire au Canada Encourager l'innovation Office of Small and Medium Enterprises (OSME) Bureau des petites et moyennes
More informationMyanmar Artemisinin Monotherapy Replacement Malaria Project (AMTR) Independent Evaluation Working Paper 4 June 2014
Myanmar Artemisinin Monotherapy Replacement Malaria Project (AMTR) Independent Evaluation Working Paper 4 June 2014 The potential impact of increased private sector investment in Myanmar on malaria control
More informationmodels for malaria elimination in the Greater Mekong Sub Region Lisa White, MAEMOD, Mahidol Oxford Tropical Medicine
Spatially explicit transmission dynamic models for malaria elimination in the Greater Mekong Sub Region Lisa White, MAEMOD, Mahidol Oxford Tropical Medicine Research Unit What is a model? A simplified
More informationBIRKS & MAYORS INC. AND CONFLICT DIAMONDS
BIRKS & MAYORS INC. AND CONFLICT DIAMONDS Birks & Mayors is very concerned about the problem of conflict diamonds. As an ambassador of the organization, it is important that each Birks and Mayors Associate
More informationBefore the FEDERAL COMMUNICATIONS COMMISSION Washington, D.C
Before the FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. 20554 In the Matter of ) ) Connect America Fund ) WC Docket No. 10-90 ) Universal Service Reform Mobility Fund ) WT Docket No. 10-208 ) Connect
More informationBecome a 2010 Census Partner
State and Local Governments Become a 2010 Census Partner In 2010, the U.S. Census Bureau will issue a call to action for every resident of our nation: Be Counted. The 2010 Census is important. It determines
More informationLife Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. Long Island JLL Research
Life Sciences Long Island 2017 An evolving industry: Today s clusters creating tomorrow s breakthroughs JLL Research Suffolk County Stony Brook University serves as an integral part of the research corridor
More informationGlobal strategy and plan of action on public health, innovation and intellectual property
SIXTY-FIRST WORLD HEALTH ASSEMBLY WHA61.21 Agenda item 11.6 24 May 2008 Global strategy and plan of action on public health, innovation and intellectual property The Sixty-first World Health Assembly,
More informationOhio Premium Cigar and Pipe Association 410 Walnut Street - Cincinnati, Ohio
Ohio Premium Cigar and Pipe Association 410 Walnut Street - Cincinnati, Ohio 45202 www.ohiocigar.org www.facebook.com/ohiocigar Chairman Peterson, and members of the Senate Ways and Means Committee, thank
More informationACCOUNTING TREATMENT OF INTELLECTUAL PROPERTY IN THE PHARMACEUTICAL INDUSTRY
Trakia Journal of Sciences, Vol. 9, No 4, pp 63-68, 2011 Copyright 2011 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7069 (print) ISSN 1313-3551 (online) Original Contribution
More informationPICK N PAY RETAIL BUYING STRUCTURE / NEW PRODUCT LISTING PROCEDURE
PICK N PAY RETAIL BUYING STRUCTURE / NEW PRODUCT LISTING PROCEDURE In years gone by, an important contributor to the success of Pick n Pay was the high degree of decentralised decision making (facilitating
More information